The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $113.91

Today's change0.00 0.00%
Updated January 23 4:00 PM EST. Delayed by at least 15 minutes.
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $113.91

Today's change0.00 0.00%
Updated January 23 4:00 PM EST. Delayed by at least 15 minutes.

Johnson & Johnson closed at (U.S.)$113.91.

Shares have lost 0.60% for the last five days, but have gained 17.74% over the last 52 weeks. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $113.91
  • High--
  • Low--
  • Bid / Ask(U.S.) $113.40 / (U.S.) $116.00
  • YTD % change-1.13%
  • Volume21
  • Average volume (10-day)6,249,491
  • Average volume (1-month)6,403,124
  • Average volume (3-month)6,886,697
  • 52-week range(U.S.) $96.04 to (U.S.) $126.07
  • Beta0.75
  • Trailing P/E19.97×
  • P/E 1 year forward16.98×
  • Forward PEG2.58×
  • Indicated annual dividend(U.S.) $3.20
  • Dividend yield2.81%
  • Trailing EPS(U.S.) $5.71
Updated January 23 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 02, 201610/02/2016Jul 03, 201607/03/2016Apr 03, 201604/03/2016Jan 03, 201601/03/2016
Revenue17,82018,48217,48217,811
Total other revenue--------
Total revenue17,82018,48217,48217,811
Gross profit12,35413,15312,17012,138
Total cost of revenue5,4665,3295,3125,673
Total operating expense12,55812,98512,22515,191
Selling / general / administrative4,7725,1764,6885,891
Research & development2,1792,2632,0132,865
Depreciation / amortization--------
Interest expense (income), net operating192190160160
Unusual expense (income)82150137723
Other operating expenses, total--------
Operating income5,2625,4975,2572,620
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax5,2814,9045,2943,758
Income after tax4,2723,9974,4573,215
Income tax, total1,009907837543
Net income4,2723,9974,4573,215
Total adjustments to net income--------
Net income before extra. items4,2723,9974,4573,215
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4,2723,9974,4573,215
Inc. avail. to common incl. extra. items4,2723,9974,4573,215
Diluted net income4,2723,9974,4573,215
Dilution adjustment--------
Diluted weighted average shares2,7852,7942,7982,800
Diluted EPS excluding extraordinary itemsvalue per share1.531.431.591.15
Dividends per sharevalue per share0.800.800.750.75
Diluted normalized EPSvalue per share1.531.431.601.57